Stocktoria
Medpace Holdings, Inc. MEDP
Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 2016-08-11
Medpace Holdings, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 21.1% | 21.2% | 17.9% | 19.1% | 17.4% |
| Net margin | 17.8% | 19.2% | 15.0% | 16.8% | 15.9% |
| FCF margin | 26.9% | 27.1% | 21.0% | 24.1% | 20.6% |
| Return on assets | 22.8% | 19.2% | 17.1% | 18.1% | 11.0% |
| Return on equity | 98.3% | 49.0% | 50.6% | 63.5% | 19.1% |
| Current ratio | 0.74 | 0.93 | 0.64 | 0.42 | 1.24 |
| Revenue growth | 20.0% | 11.8% | 29.2% | 27.8% | 23.4% |
Source: SEC EDGAR filings · CIK 0001668397 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.